Equities analysts expect NCI, Inc. (NASDAQ:NCIT) to announce $0.25 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for NCI’s earnings. NCI posted earnings per share of $0.23 during the same quarter last year, which suggests a positive year over year growth rate of 8.7%. The company is scheduled to issue its next earnings results on Wednesday, August 2nd.
On average, analysts expect that NCI will report full-year earnings of $1.00 per share for the current fiscal year, with EPS estimates ranging from $1.00 to $1.01. For the next year, analysts anticipate that the firm will post earnings of $1.09 per share, with EPS estimates ranging from $1.05 to $1.15. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side research analysts that cover NCI.
NCI (NASDAQ:NCIT) last announced its earnings results on Tuesday, May 9th. The information technology services provider reported $0.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.21 by $0.04. The company had revenue of $78.75 million during the quarter, compared to analysts’ expectations of $76.55 million. NCI had a net margin of 2.13% and a return on equity of 11.73%.
A number of analysts have commented on the stock. SunTrust Banks, Inc. reaffirmed a “buy” rating on shares of NCI in a research note on Monday, June 26th. Noble Financial reissued a “buy” rating on shares of NCI in a research report on Friday, May 12th. ValuEngine raised shares of NCI from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Cowen and Company reissued a “buy” rating and issued a $24.00 price target on shares of NCI in a research report on Monday, July 3rd. Finally, Zacks Investment Research lowered shares of NCI from a “hold” rating to a “sell” rating in a research report on Saturday, April 8th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. NCI has a consensus rating of “Hold” and an average target price of $18.33.
Several hedge funds have recently bought and sold shares of NCIT. Geode Capital Management LLC raised its stake in NCI by 6.7% in the first quarter. Geode Capital Management LLC now owns 90,650 shares of the information technology services provider’s stock worth $1,364,000 after buying an additional 5,688 shares during the period. Royce & Associates LP bought a new stake in NCI during the first quarter worth about $7,663,000. ClariVest Asset Management LLC raised its stake in NCI by 5.3% in the first quarter. ClariVest Asset Management LLC now owns 14,464 shares of the information technology services provider’s stock worth $217,000 after buying an additional 727 shares during the period. Hancock Holding Co. bought a new stake in NCI during the first quarter worth about $189,000. Finally, Bank of New York Mellon Corp raised its stake in NCI by 4.4% in the first quarter. Bank of New York Mellon Corp now owns 27,972 shares of the information technology services provider’s stock worth $421,000 after buying an additional 1,184 shares during the period. 38.46% of the stock is owned by institutional investors and hedge funds.
NCI (NASDAQ NCIT) traded up 0.25% during trading on Tuesday, hitting $20.00. 103,325 shares of the stock were exchanged. NCI has a 12-month low of $10.98 and a 12-month high of $21.40. The stock’s 50-day moving average price is $20.22 and its 200-day moving average price is $16.43. The firm has a market cap of $182.34 million, a PE ratio of 45.45 and a beta of 1.04.
NCI Company Profile
NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for NCI Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCI Inc. and related companies with MarketBeat.com's FREE daily email newsletter.